Valeant Pharmaceuticals Intl Inc news

   Watch this stock
Showing stories 1 - 10 of about 177   

Articles published

VRX 26.28 +0.39 (1.51%)
price chart
Valeant Pharmaceuticals International Inc sued over ties to Philidor RX ...
NEW YORK - Valeant Pharmaceuticals International Inc was sued on Monday by buyers of its drugs, who accused the Canadian company of racketeering by forcing them to pay exorbitant prices.
Can Valeant Pharmaceuticals Intl Inc. Recover From its Implosion?  The Motley Fool Canada
Valeant Pharmaceuticals Intl Inc (VRX) Stock : Shadows Stronger Than Light  TCC
Valeant Pharmaceuticals Intl Inc: VRX Stock to Regain Value?
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock, the once-high-flying Wall Street favorite, suffered not just one, but several major blows that knocked the company down to its knees.
Revenue Estimates Analysis: Valeant Pharmaceuticals International, Inc ...  News Oracle
Analysts Chime in on Healthcare Giants Valeant Pharmaceuticals Intl Inc (VRX ...  Smarter Analyst
More Problems for Valeant Pharmaceuticals Intl Inc.
Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) continues to suffer from a myriad of problems, both old and new. Most of those problems started last year as exposure to drug-pricing practices, a questionable arrangement with a pharmacy, and an ...
Valeant Pharmaceuticals Intl Inc (VRX) Tests Support After Papa Comments  Schaeffers Research (blog)
Stock Update (NYSE:VRX): Valeant Pharmaceuticals Intl Inc And Progenics ...  Smarter Analyst
The Smart Money Is Buying Valeant Pharmaceuticals Intl Inc.: Should You Buy Too?
Chou's Associates Fund recently took on a controversial position, buying approximately one million Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) shares. Let's take a closer look at why Chou thought the troubled company was a good buy.
Valeant Stock: Many Are Bullish on Valeant Pharmaceuticals Intl Inc
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is slowly but surely moving higher. Indeed, if we are to give credence to its CEO Joseph Papa, Valeant stock is poised for a nice recovery by the start of 2017.
Deutsche Bank AG (DB) Covers Valeant Pharmaceuticals International, Inc ...  TCC
Analysts Mixed on Two Biotech Giants: Valeant Pharmaceuticals Intl Inc (VRX ...  Smarter Analyst
Valeant's new CFO to review 2016 numbers, CEO says, despite '16 forecast being ...
Valeant Pharmaceuticals International Inc.'s new chief financial officer will review the drugmaker's numbers for this year and next after the company surprised the market in August by reaffirming its 2016 forecast, Chief Executive Officer Joe Papa said ...
Valeant Pharmaceuticals International, Inc. (NYSE:VRX) to Write Down 90% or ...
According to FactSet Fundamentals, the Street has six Buy, one Overweight, 12 Hold, and three Sell ratings on Valeant shares, implying an overall Neutral stance.
Valeant Pharmaceuticals: How Much Downside?  Seeking Alpha
Stock's Ratings to Focus: Valeant Pharmaceuticals International, Inc ...  Street Updates
Valeant Pharmaceuticals International, Inc.'s (VRX) Agreement with Orexigen ...
Canadian drug-maker Valeant Pharmaceuticals Intl.'s (NYSE:VRX) Canada Division reached an agreement with Orexigen Therapeutics over the commercialization of Contrave in Canada.
How Far Will Valeant Pharmaceuticals Intl Inc (VRX) Go to Shed its Billions in ...
As Valeant Pharmaceuticals Intl Inc (NYSE:VRX) CEO Joe Papa attempts to navigate its water-logged helm, he has suddenly changed course.
Would Valeant Pharmaceuticals International, Inc. (VRX) Succeed in Clearing ...  TCC
Market Mover Alert: Valeant Pharmaceuticals International, Inc.'s (VRX)  Is stories
Valeant Pharmaceuticals Intl Inc (NYSE:VRX): Price Reaction History
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) soared 0.31% during previous trade, a total of 15.45M shares exchanged hands compared with its average trading volume of 30.01M shares whereas its relative volume is 0.52.
Valeant Pharmaceuticals Intl Inc (VRX): Here's Why Investors Seem Dazed  TCC
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Stocks News Update: 01 Sep 2016  Money News